Exclusive

Publication

Byline

Location

US Patent Issued to ENDEAVOR HEALTH CLINICAL OPERATIONS, MULTIVIR on Aug. 18 for "Methods and compositions comprising enhanced targeted immune gene therapy for the treatment of cancer" (Illinois, Texas Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,653, issued on Aug. 18, was assigned to ENDEAVOR HEALTH CLINICAL OPERATIONS (Evanston, Ill.) and MULTIVIR INC. (Houston). "Methods and comp... Read More


US Patent Issued to Abalos Therapeutics on Aug. 18 for "Virus particles for therapeutic purposes" (German Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,654, issued on Aug. 18, was assigned to Abalos Therapeutics GmbH (Dusseldorf, Germany). "Virus particles for therapeutic purposes" was inve... Read More


US Patent Issued to Arbor Life Holdings on Aug. 18 for "Botanicals as WNT/beta-catenin activators, molecular pathway regulators, tissue regenerators and health biomarker regulators" (Canadian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,655, issued on Aug. 18, was assigned to Arbor Life Holdings Ltd. (Thornhill, Canada). "Botanicals as WNT/beta-catenin activators, molecular... Read More


US Patent Issued to University of South Florida, Washington University on Aug. 18 for "Peptide-polynucleotide-hyaluronic acid nanoparticles and methods for polynucleotide transfection" (Florida, Missouri Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,656, issued on Aug. 18, was assigned to University of South Florida (Tampa, Fla.) and Washington University (St. Louis). "Peptide-polynucle... Read More


US Patent Issued to AMYLOID SOLUTION on Aug. 18 for "Pharmaceutical composition for treating degenerative brain disease, including glycine transporter as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,657, issued on Aug. 18, was assigned to AMYLOID SOLUTION INC. (Seongnam-si, South Korea). "Pharmaceutical composition for treating degenera... Read More


US Patent Issued to Zensun (Shanghai) Science & Technology on Aug. 18 for "Compositions and methods for treating heart failure" (Chinese Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,658, issued on Aug. 18, was assigned to Zensun (Shanghai) Science & Technology Co. Ltd. (Shanghai). "Compositions and methods for treating ... Read More


US Patent Issued to KIMBALL WESTWARD on Aug. 18 for "Polyphenolic insulin" (Maryland Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,659, issued on Aug. 18, was assigned to KIMBALL WESTWARD LLC (Sheridan, Wyo.). "Polyphenolic insulin" was invented by Robert R. Reddy (Fred... Read More


US Patent Issued to THE BIOREGENTECH INSTITUTE on Aug. 18 for "Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods" (California Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,660, issued on Aug. 18, was assigned to THE BIOREGENTECH INSTITUTE INC. (Irvine, Calif.). "Therapeutic systems, devices, and compositions w... Read More


US Patent Issued to Ipsen Biopharm on Aug. 18 for "Treatment of brain damage" (British Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,661, issued on Aug. 18, was assigned to Ipsen Biopharm Ltd. (Wrexham, Great Britain). "Treatment of brain damage" was invented by Mikhail K... Read More


US Patent Issued to Oklahoma Medical Research Foundation on Aug. 18 for "Monoclonal antibody against human activated protein C and preparation and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,662, issued on Aug. 18, was assigned to Oklahoma Medical Research Foundation (Oklahoma City). "Monoclonal antibody against human activated ... Read More